NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Godrej Agrovet Sees Improvement in Q4FY26 Results

Godrej Agrovet (GOAGRO) has released its quarterly performance report for Q4FY26, showcasing a mixed bag of results. The company's recurring EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stood at INR 1.4 billion, representing a 5% decline year-over-year (YoY). However, the company's recurring PAT (Profit After Tax) witnessed a significant improvement, rising by 14% to INR 0.8 billion YoY.

A closer examination of the company's performance reveals that the strength in animal nutrition and foods segments has helped offset the weakness in crop protection and vegetable oil segments. Notably, Astec, a part of the crop protection segment, delivered positive EBITDA for the quarter, marking a significant improvement from the loss of INR 610 million in FY25. The company's FY26 EBITDA is now at a positive level.

Positive Trends Ahead

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The research report by ICICI Securities suggests that the next 12 to 18 months are likely to witness stronger trends in the animal feed and vegetable oil segments. Additionally, the recovery in Astec is expected to continue, and the crop protection segment is anticipated to benefit from a relatively better application window.

Recommendation

ICICI Securities has maintained its BUY recommendation for Godrej Agrovet with a revised target price (TP) of INR 900. The research firm has also downward revised its earnings per share (EPS) estimates for FY27E and FY28E by 3% and 2%, respectively. The downward revisions are primarily due to the crop protection segment, while the animal nutrition and Astec segments have seen upward revisions.

SegmentQ4FY26 EBITDA (YoY)FY26 EBITDA (YoY)
Animal Nutrition and Foods
Crop Protection-+
Vegetable Oil--
Astec++

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Note: The table above highlights the YoY performance of each segment.

Investor Takeaway

Maintain BUY with a revised TP of INR 900.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.